Clinical Evidence
254 results
HDx therapy enabled by Theranova
Improved Removal of Free Light Chains by Hemodialysis With Medium Cut-Off Dialyzer
HDx therapy enabled by Theranova
Improved Serum Phosphorous and Small Molecule Removal With Expanded Hemodialysis and Hemodiafiltration vs. Conventional Hemodialysis: A Cross-Over Randomized Clinical Trial
HDx therapy enabled by Theranova
Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial
HDx therapy enabled by Theranova
In vitro benchmark of cytokine removal by dialyzers with various permeability profiles
HDx therapy enabled by Theranova
In Vitro Cytokine Removal: Comparison of Conventional High-Flux Dialyzers and Middle-Cut-Off Dialyzer (Theranova HDx)
HDx therapy enabled by Theranova
Innovations of renal replacement techniques at the intersection of clinical trial and real-world data.
HDx therapy enabled by Theranova
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration
HD
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration - Leypoldt et al.
HD
Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions? - Dolley-Hitze T et al
HDx therapy enabled by Theranova
Is Expanded Hemodialysis an Option to Online Hemodiafiltration for Small- and Middle-Sized Molecules Clearance?
HDx therapy enabled by Theranova
Large Middle Molecule and Albumin Removal: Why Should We Not Rest on Our Laurels?
HDx therapy enabled by Theranova
Large uremic toxins: an unsolved problem in end-stage kidney disease - Wolley MJ and Hutchison CA.
Vantive is a trademark of Vantive Health LLC or its affiliates.